NeuroStar wins approval for antidepression device in S. Korea

08/23/2013 | BioSpectrum Asia

NeuroStar has received the go-ahead to market its Transcranial Magnetic Stimulation device in South Korea. The device, which stimulates neurons in certain areas of the brain by transmitting highly focused magnetic pulses, is designed to provide a noninvasive and drug-free alternative to treating patients with major depression.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN